tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
DoseFinding vs epidemics
A side-by-side editorial comparison of DoseFinding and epidemics — release velocity, themes, recent moves, and the top alternatives to consider.
DoseFinding vs epidemics: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is epidemics?
epidemics swapped its C++ engine for odin — and quietly inverted how contact matrices must be passed.
epidemics ships composable compartmental model structures — default SEIR-V, Vacamole, diphtheria and Ebola — with classes for populations, interventions and vaccination campaigns. After more than two years without a release, 0.5.0 landed in July 2026 carrying both an engine migration and a breaking input-convention change. Maintainership moved to a new lead back in 0.4.0.
DoseFinding vs epidemics: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
epidemics
3.8ANALYTICS
epidemics swapped its C++ engine for odin — and quietly inverted how contact matrices must be passed.
◆ Current state
epidemics ships composable compartmental model structures — default SEIR-V, Vacamole, diphtheria and Ebola — with classes for populations, interventions and vaccination campaigns. After more than two years without a release, 0.5.0 landed in July 2026 carrying both an engine migration and a breaking input-convention change. Maintainership moved to a new lead back in 0.4.0.
◆ Where it's heading
The package's history is a sequence of deliberate breaking releases: 0.2.0 renamed every model function and vectorised the ODE models, 0.3.0 restructured the Ebola model into two levels and made replicates the default, and 0.5.0 rewrites the compiled core. The direction is toward a smaller, more declarative model definition layer with the numerical work delegated to a dedicated tool.
◆ Prediction
With the default, Vacamole and diphtheria systems now declared in odin, the Ebola model is the obvious remaining candidate for the same treatment.
Alternatives to DoseFinding and epidemics
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or epidemics.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all DoseFinding alternatives → · See all epidemics alternatives →
Recent activity from DoseFinding and epidemics
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 25d agoepidemicsODE models migrate to odin; contact matrices must no longer be transposed ⚡
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoepidemicsPeak timing and scenario comparison helpers; negative-susceptible bug fixed
- 2y agoepidemicsEbola model accepts vector inputs and defaults to 100 replicates
- 2y agoepidemicsODE models vectorised; every model function renamed
- 2y agoepidemicsFirst release: four composable compartmental model structures
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between DoseFinding and epidemics?
They serve adjacent needs but don't currently overlap on shipped themes. epidemics is currently shipping more aggressively (velocity 3.8 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than epidemics?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. epidemics is currently shipping more aggressively (velocity 3.8 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to epidemics?
Top epidemics alternatives in Analytics are ranked by recent ship velocity. Browse the "epidemics alternatives" section above for the current picks, or visit /alternatives/epidemics for the full list with editorial commentary on each.